Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613000276752
Ethics application status
Approved
Date submitted
17/02/2013
Date registered
7/03/2013
Date last updated
8/04/2021
Date data sharing statement initially provided
8/04/2021
Type of registration
Retrospectively registered

Titles & IDs
Public title
Pilot study to evaluate the incidence and nature of unplanned medical visits for patients with early breast cancer during the course of their management following surgery: PATIPS-A
Scientific title
Pilot study to evaluate the incidence and nature of unplanned medical visits for patients with early breast cancer during the course of their management following surgery: PATIPS-A
Secondary ID [1] 281975 0
None
Universal Trial Number (UTN)
Trial acronym
PATIPS-A
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Breast Cancer 288403 0
Condition category
Condition code
Cancer 288751 288751 0 0
Breast

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
We are aiming to collect details of the side effects that you experience during each phase of your treatment, how often and the reason that you see your GP or specialist during your breast cancer treatment for unexpected medical problems; and what treatment is given to you for these medical problems.
The information will be collected in a patient self-reported diary and sourced in routine medical practice medical file notes. Paticipants will be observed until completion of their designated treatments - this will range from 2 to 6 months depending on which treatments the participant undergoes.
Intervention code [1] 286546 0
Not applicable
Comparator / control treatment
N/A
Control group
Uncontrolled

Outcomes
Primary outcome [1] 288892 0
The nature and frequency of adverse events related to surgery, chemotherapy and/or radiation therapy in patients with early breast cancer.
Typical adverse events would include seroma, wound infection, moist desquamation, neutropenic sepsis. This will be assessed by the patient self report diary.
Timepoint [1] 288892 0
End of study assessment.
Secondary outcome [1] 301250 0
First point of medical contact for management of adverse event
Assessed by patient self report diary and routine medical file notes
Timepoint [1] 301250 0
End of Study
Secondary outcome [2] 301620 0
Treatment recommended for adverse event
Assessed by patient self report diary and routine medical file notes
Timepoint [2] 301620 0
End of study
Secondary outcome [3] 301621 0
Adverse event outcome
Assessed by patient self report diary and routine medical file notes
Timepoint [3] 301621 0
End of study
Secondary outcome [4] 301622 0
Rates and reason for hospitalisation
Assessed by patient self report diary and routine medical file notes
Timepoint [4] 301622 0
End of study

Eligibility
Key inclusion criteria
i. Patient consent
ii. Consecutive patients who will be receiving radiation therapy and/or who will receive chemotherapy.
iii. English is the first language
iv. Residential address in the Perth greater metropolitan area
v. Regular GP as defined by the patient or no regular GP available. (GP consent is not considered necessary as SP and GP have recognised joint responsibility for the patient and if the patient consents to study, it is implied that communications between the GP and SP is freely provided)
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
i. Patient not to receive either chemotherapy or radiation therapy

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
17/02/2013
Actual
1/03/2013
Date of last participant enrolment
Anticipated
28/02/2014
Actual
1/05/2015
Date of last data collection
Anticipated
Actual
21/03/2016
Sample size
Target
30
Accrual to date
Final
30
Recruitment in Australia
Recruitment state(s)
WA
Recruitment postcode(s) [1] 6354 0
6000 - Perth

Funding & Sponsors
Funding source category [1] 286752 0
Charities/Societies/Foundations
Name [1] 286752 0
Breast Cancer Research Centre - WA
Country [1] 286752 0
Australia
Primary sponsor type
Charities/Societies/Foundations
Name
Breast Cancer Research Centre - WA
Address
Hollywood Consulting Centre
Suite 407, 4th Floor
91 Monash Avenue
Nedlands WA 6009
Country
Australia
Secondary sponsor category [1] 285532 0
None
Name [1] 285532 0
Address [1] 285532 0
Country [1] 285532 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 288821 0
Mount Hospital
Ethics committee address [1] 288821 0
Ethics committee country [1] 288821 0
Australia
Date submitted for ethics approval [1] 288821 0
07/01/2013
Approval date [1] 288821 0
05/02/2013
Ethics approval number [1] 288821 0
EC73.2

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 37934 0
Prof Arlene Chan
Address 37934 0
Breast Cancer Research Centre,-WA, Suite 407, Hollywood Consulting Centre, 91 Monash Avenue, Nedlands, 6009 WA
Country 37934 0
Australia
Phone 37934 0
+61 8 94814522
Fax 37934 0
+61 8 94814544
Email 37934 0
[email protected]
Contact person for public queries
Name 37935 0
Arlene Chan
Address 37935 0
Breast Cancer Research Centre,-WA, Suite 407, Hollywood Consulting Centre, 91 Monash Avenue, Nedlands, 6009 WA
Country 37935 0
Australia
Phone 37935 0
+61 8 94814522
Fax 37935 0
+61 8 94814544
Email 37935 0
[email protected]
Contact person for scientific queries
Name 37936 0
Arlene Chan
Address 37936 0
Breast Cancer Research Centre,-WA, Suite 407, Hollywood Consulting Centre, 91 Monash Avenue, Nedlands, 6009 WA
Country 37936 0
Australia
Phone 37936 0
+61 8 94814522
Fax 37936 0
+61 8 94814544
Email 37936 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.